These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 4952639)

  • 1. An unusual case of isoimmunization by D, Cellano (k) and Duffy (Fyb) antigens.
    Chojnacka-Jachimiak I; Seyfried H; Koziołowa H
    Arch Immunol Ther Exp (Warsz); 1971; 19(5):585-91. PubMed ID: 4952639
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregnancy outcome in mothers who develop Kell antibodies.
    Farr V; Gray E
    Scott Med J; 1988 Aug; 33(4):300-3. PubMed ID: 3055288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serologic incompatibility and family planning].
    Matýsek P; Ungerová A; Cuprová M; Muchová M
    Cesk Gynekol; 1988 Aug; 53(7):497-9. PubMed ID: 3168017
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood transfusion complications due to Duffy factor (Fya) incompatibility].
    Umnova MA; Skachilova NN; Piskunova TM; Molchanova NP; Shakhsuvarov VD
    Probl Gematol Pereliv Krovi; 1982 Dec; 27(12):11-5. PubMed ID: 7156083
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood transfusion complications due to Kell factor incompatibility of the transfused blood].
    Skachilova NN; Umnova MA; Morozova AD; Shakhsuvarov VD; Beliaev VV
    Probl Gematol Pereliv Krovi; 1982 Dec; 27(12):16-20. PubMed ID: 7156084
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood transfusion complication in a female patient with a rare KK blood genotype].
    Umnova MA; Skachilova NN; Piskunova TM; Ichalovskaia TA; Morozova AD
    Probl Gematol Pereliv Krovi; 1982 Dec; 27(12):45-9. PubMed ID: 7156087
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood transfusion: the hidden dangers.
    Anderson T
    Pract Midwife; 2004 Mar; 7(3):12-6. PubMed ID: 15058056
    [No Abstract]   [Full Text] [Related]  

  • 8. [A clinical case of pregnancy isoimmunization caused by the Kell system].
    Orsini G; Serratì A; Schonauer S; Cramarossa D
    Minerva Ginecol; 1977 Oct; 29(10):727-30. PubMed ID: 593610
    [No Abstract]   [Full Text] [Related]  

  • 9. [Kell antibodies in pregnancy].
    Rempen A; Schweppe KW
    Z Geburtshilfe Perinatol; 1983; 187(4):183-90. PubMed ID: 6684844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolytic disease of the newborn caused by maternal allo-immunization against erythrocyte antigens other than A, B and rhesus D].
    Monestier M; Rigal D; Juron-Dupraz F; Meyer F
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):671-80. PubMed ID: 6520354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Rh0 (D) hemolytic disease of the newborn: an obstetric viewpoint.
    Zlatnik FJ
    Semin Perinatol; 1977 Apr; 1(2):169-75. PubMed ID: 754292
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of antisera for bloodstain grouping. II. Ss, Kell, Duffy, Kidd, and Gm/Km.
    Gaensslen RE; Lee HC; Pagliaro EM; Bremser JK; Carroll-Reho J
    J Forensic Sci; 1985 Jul; 30(3):655-76. PubMed ID: 4031801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
    Wenk RE; Goldstein P; Felix JK
    Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hemolytic transfusion reaction caused by anti-Fyb in a splenectomized patient.
    Boyland IP; Mufti GJ; Hamblin TJ
    Transfusion; 1982; 22(5):402. PubMed ID: 7123642
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of blood group antigens and release of amino acids induced by dispase treatment.
    Ikemoto S; Miyake B; Yoshida H; Tomita K
    Nihon Hoigaku Zasshi; 1984 Feb; 38(1):1-4. PubMed ID: 6381830
    [No Abstract]   [Full Text] [Related]  

  • 17. Kell alloimmunization in pregnancy: associated with fetal thrombocytopenia?
    van den Akker ES; Klumper FJ; Brand A; Kanhai HH; Oepkes D
    Vox Sang; 2008 Jul; 95(1):66-9. PubMed ID: 18435678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current clinical concepts in hemolytic disease and blood group incompatibility.
    Cherry SH
    Prog Clin Biol Res; 1981; 70():205-12. PubMed ID: 6273933
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic factors and management in pregnancies complicated with severe kell alloimmunization: experiences of the last 13 years.
    Babinszki A; Lapinski RH; Berkowitz RL
    Am J Perinatol; 1998; 15(12):695-701. PubMed ID: 10333397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case of post-transfusion shock caused by alloimmunization with antigens E and Duffy (Fya)].
    Grzywak-Kołodziejczyk T; Skotnicka B; Kołodziejczyk M; Lawniczak K; Samek E
    Wiad Lek; 1981 May; 34(9):761-6. PubMed ID: 6792791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.